Gunnar Juliusson Selected Research

Gunnar Juliusson Research Topics

Disease

19	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 06/2003
14	Neoplasms (Cancer) 01/2019 - 06/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 04/2003
12	Leukemia 01/2021 - 07/2004
9	Multiple Myeloma 04/2014 - 04/2004
2	Acute Promyelocytic Leukemia 10/2021 - 04/2012
2	Residual Neoplasm 01/2021 - 10/2016
2	Multiple Sclerosis 01/2021 - 12/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2013 - 11/2005
2	Hematologic Neoplasms (Hematological Malignancy) 10/2012 - 07/2004
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2011 - 08/2011
2	Hairy Cell Leukemia 06/2011 - 10/2006
2	Fever (Fevers) 12/2003 - 06/2003
1	COVID-19 01/2021
1	Pathologic Complete Response 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Wilms Tumor (Wilm's Tumor) 10/2017
1	Hypersensitivity (Allergy) 10/2017
1	Smoldering Multiple Myeloma 01/2017
1	Cholangiocarcinoma 12/2016
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2016
1	Hematologic Diseases (Blood Diseases) 03/2015
1	Disease Progression 11/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2014
1	Bronchiolitis Obliterans Syndrome 12/2013
1	Dizziness (Lightheadedness) 10/2012
1	Headache (Headaches) 10/2012
1	Confusion (Bewilderment) 10/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2012
1	Fatigue 10/2012
1	Bone Diseases (Bone Disease) 10/2010
1	Osteonecrosis (Kienbock's Disease) 10/2010
1	Infections 09/2009
1	Neuroblastoma 09/2009

Drug/Important Bio-Agent (IBA)

8	Cladribine FDA LinkGeneric 01/2021 - 10/2003
7	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 06/2003
7	Biological ProductsIBA 01/2019 - 06/2005
5	Thalidomide (Thalomid)FDA Link 04/2014 - 04/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2006
4	AntibodiesIBA 01/2016 - 05/2013
4	Melphalan (Alkeran)FDA LinkGeneric 04/2014 - 01/2008
3	NucleophosminIBA 01/2020 - 10/2016
3	Messenger RNA (mRNA)IBA 10/2017 - 03/2006
3	fludarabineIBA 02/2016 - 03/2006
3	Prednisone (Sone)FDA LinkGeneric 04/2014 - 09/2010
3	AntigensIBA 09/2010 - 06/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2009
2	Monoclonal AntibodiesIBA 01/2017 - 06/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016 - 01/2008
2	purineIBA 12/2014 - 10/2006
2	Chlorambucil (Leukeran)FDA Link 12/2014 - 09/2009
2	RNA (Ribonucleic Acid)IBA 07/2012 - 08/2011
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2010 - 11/2004
2	NucleosidesIBA 03/2005 - 07/2004
2	EpitopesIBA 11/2004 - 06/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2003 - 04/2003
1	DiterpenesIBA 10/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017
1	InterferonsIBA 10/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 02/2016
1	Therapeutic UsesIBA 08/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2015
1	Bortezomib (Velcade)FDA Link 04/2014
1	Interleukin-33IBA 05/2013
1	InterleukinsIBA 05/2013
1	eprenetapoptIBA 10/2012
1	Tyrosine (L-Tyrosine)FDA Link 03/2011
1	lestaurtinibIBA 03/2011
1	Diphosphonates (Bisphosphonates)IBA 10/2010
1	Pamidronate (Aredia)FDA LinkGeneric 10/2010
1	Clofarabine (Clolar)FDA Link 12/2009
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2009
1	Bendamustine Hydrochloride FDA Link 09/2009
1	OligonucleotidesIBA 08/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2008
1	Vincristine (Oncovin)FDA LinkGeneric 01/2008
1	deoxyguanosine kinaseIBA 03/2006
1	ProdrugsIBA 03/2006
1	DeoxycytidineIBA 03/2006
1	Deoxycytidine KinaseIBA 03/2006
1	2-chloroadenineIBA 07/2004

Therapy/Procedure

14	Therapeutics 10/2021 - 06/2003
8	Stem Cell Transplantation 01/2021 - 01/2008
5	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
3	Hematopoietic Stem Cell Transplantation 12/2013 - 11/2005
3	Transplantation 01/2013 - 11/2005
2	Intravenous Infusions 10/2012 - 10/2010
1	Treatment Delay 01/2021
1	Palliative Care (Palliative Therapy) 03/2015
1	Combination Drug Therapy (Combination Chemotherapy) 04/2012
1	Immunotherapy 09/2009
1	Aftercare (After-Treatment) 10/2006
1	Homologous Transplantation 06/2005